Sentinus LLC’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$1.24M	Buy	167,275 +18,225	+12%	+$135K	0.39%	49
2023 Q1	$1.41M	Buy	149,050 +126,050	+548%	+$1.19M	0.47%	44
2022 Q4	$272K	Buy	23,000 +500	+2%	+$5.9K	0.16%	90
2022 Q3	$166K	Buy	+22,500	New	+$166K	0.1%	104